A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma
Source: biopharmadive.com
📰 Third Harmonic Bio News
Page 4 - Third Harmonic Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Third Harmonic Bio. Real-time updates on events, politics, business and more.
Stocks To Watch: Inflation Reads And Bank Earnings To Dominate The Action
Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week
Source: seekingalpha.com
Biotech IPO market slowdown continues as third quarter is weakest since 2011
Third Harmonic Bio’s stock market debut was the only biotech IPO that crossed the $100 million threshold in the third quarter as the slowdown in IPO activity showed little sign of changing. Small deals continue to represent most of the IPO activity.
United Kingdom Third Harmonic Bio Massachusetts Based Third Harmonic Prime Medicine Weight Loss Medical Devices
Source: medcitynews.com
Acelyrin Raises $300M to Further Growth - San Fernando Valley Business Journal
Acelyrin Inc. has raised $300 million in a Series C round to accelerate its treatments for inflammatory diseases.
Source: sfvbj.com
Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Portfolio Company Update: Third Harmonic Bio IPO
Investegate announcements from RTW Venture Fund Ltd, Portfolio Company Update: Third Harmonic Bio IPO
Source: investegate.co.uk
Third Harmonic Bio Announces Pricing of Upsized Initial
CAMBRIDGE, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a...
Source: globenewswire.com